trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Hydroxychloroquine and corticosteroids are primary medications used to treat systemic lupus erythematosus.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Hydroxychloroquine and corticosteroids are primary medications used to treat systemic lupus erythematosus?

Yes. Hydroxychloroquine and corticosteroids are well-established primary medications in the clinical management of systemic lupus erythematosus.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently confirms that hydroxychloroquine and corticosteroids (glucocorticoids) form the cornerstone of standard therapy for systemic lupus erythematosus and its renal manifestations. Multiple papers mention them as standard background or foundational treatments.

Evidence for · 7
Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report
2014
Hydroxychloroquine is identified and used as a standard medication for systemic lupus erythematosus in this case report.
Get citation
Galil, S. M. A. (2014). Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report. doi.org. https://doi.org/10.1177/0961203314561667

See more details
More for · 6
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
2023
The study discusses hydroxychloroquine dosage and blood levels in the routine treatment of systemic lupus erythematosus.
Get citation
Fasano, S., Messiniti, V., Iudici, M., Coscia, M. A., & Ciccia, F. (2023). Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus. doi.org. https://doi.org/10.1136/lupus-2022-000841

Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis.
2026
Mycophenolate treatment regimens for lupus nephritis commonly combine glucocorticoids and hydroxychloroquine as baseline therapy.
Get citation
B, L., L, C., J, L., X, L., X, L., Z, H., M, H., K, T., X, J., & P, C. (2026). Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis.. doi.org. https://doi.org/10.1002/phar.70127

Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization.
2026
Contemporary guidance establishes hydroxychloroquine and steroid regimens as the foundation of care for childhood-onset lupus erythematosus.
Get citation
MS, A. R., B, A. G., S, A. S., A, A. O., N, A. K., & N, A. D. (2026). Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization.. doi.org. https://doi.org/10.3390/children13070930

Does Voclosporin Redefine Lupus Nephritis Treatment? A Tri-Focal View of Efficacy, Safety, and Costs.
2026
Glucocorticoids (corticosteroids) and hydroxychloroquine are explicitly listed as standard baseline therapy for lupus nephritis in systemic lupus erythematosus.
Get citation
TT, Z., MH, L., XH, Z., YF, T., BK, C., ZK, K., & XJ, L. (2026). Does Voclosporin Redefine Lupus Nephritis Treatment? A Tri-Focal View of Efficacy, Safety, and Costs.. doi.org. https://doi.org/10.1007/s11596-026-00217-5

Hydroxychloroquine Ocular Toxicity: A Comprehensive Review.
2026
Hydroxychloroquine is recognized as a primary pharmacological agent in the management of systemic lupus erythematosus.
Get citation
M, S., RH, M., & AJ, K. (2026). Hydroxychloroquine Ocular Toxicity: A Comprehensive Review.. doi.org. https://doi.org/10.3899/jrheum.2025-0127

Discoid Lupus Erythematosus Successfully Treated With Anifrolumab.
2026
Corticosteroids and antimalarials like hydroxychloroquine are cited as standard first-line treatments for lupus erythematosus.
Get citation
J, B., S, W., & S, H. (2026). Discoid Lupus Erythematosus Successfully Treated With Anifrolumab.. doi.org. https://doi.org/10.7759/cureus.108173

What does the evidence say?

The retrieved literature consistently confirms that hydroxychloroquine and corticosteroids (glucocorticoids) form the cornerstone of standard therapy for systemic lupus erythematosus and its renal manifestations. Multiple papers mention them as standard background or foundational treatments.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8504 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work